“Impact of a Prognostic 40-Gene Expression Profiling Test on Clinical Management Decisions for High-Risk Cutaneous Squamous Cell Carcinoma”. SKIN The Journal of Cutaneous Medicine, vol. 4, no. 5, Sept. 2020, p. s64, https://doi.org/10.25251/skin.4.supp.63.